文献速递咽喉与嗓音小儿耳鼻咽喉

泼尼松减少成人良性口咽手术患者的阿片类药物使用

Prednisone Decreases Opioid Use in Adults Undergoing Benign Oropharyngeal Surgery.
PubMed 文献 · Otolaryngol Head Neck Surg · 2023-09-13

这项前瞻性队列研究纳入2020年12月至2023年1月接受扁桃体切除术、扁桃体腺样体切除术和/或改良悬雍垂腭咽成形术的成人患者72例,比较接受与未接受术后泼尼松 taper 的队列。非激素组平均使用467±94.1 MME,激素组平均使用285±128 MME(P<0.001),非激素组阿片类药物消耗量为激素组的1.62倍(P<0.002)。两组并发症率、续药率和疼痛评分无显著差异。

要点

  • 非激素组平均消耗467±94.1 MME,激素组285±128 MME(P<0.001)。
  • 非激素组阿片消耗量为激素组的1.62倍(P<0.002)。
  • 两组并发症率、续药率及术后第1、5、10天疼痛评分无显著差异。

核心结论

  • 未接受激素的患者术后阿片类药物消耗量是完成激素逐渐减量患者的1.62倍。
  • 使用皮质类固醇与疼痛评分、续药率或并发症率的变化无关,可考虑作为成人良性口咽手术多模式疼痛管理的一部分,但需要进一步研究。

研究设计与样本

  • 前瞻性队列研究,单中心三级医疗机构。
  • 纳入2020年12月至2023年1月接受扁桃体切除术、扁桃体腺样体切除术和/或改良悬雍垂腭咽成形术的患者72例。
  • 根据是否开具术后激素分为非激素组(N=29)和激素组(N=43),泼尼松逐渐减量方案取决于外科医生偏好。

主要发现

  • 非激素组平均消耗467±94.1 MME,激素组平均消耗285±128 MME(P<0.001)。
  • 非激素组阿片类药物消耗量为激素组的1.62倍(P<0.002)。
  • 两组并发症率或续药率无显著差异。
  • 手术当天及术后第1、5、10天疼痛评分无显著差异(分别为P=0.34、P=0.66、P=0.62、P=0.22)。
  • 接受扁桃体腺样体切除术(P=0.019)或当前使用精神科药物(P<0.006)的患者阿片类药物消耗量显著更多。

临床怎么用

  • 作者认为,皮质类固醇使用可考虑作为成人良性口咽手术多模式疼痛管理的一部分,但需要进一步研究。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study sought to analyze the efficacy and safety of postoperative prednisone to reduce reliance on opioids in adult benign oropharyngeal surgery. STUDY DESIGN: Prospective cohort study. SETTING: Single tertiary-care facility. METHODS: Patients undergoing tonsillectomy (T), tonsillectomy and adenoidectomy (T&A), and/or modified uvulopalatopharyngoplasty (UPPP) from December 2020 to January 2023 received the standard of care postoperative management. A prednisone taper was dependent on surgeon preference. Cohorts were based on the prescription of postoperative steroids. Patients completed a survey to assess opioid usage, pain scores, and steroid compliance. RESULTS: Seventy-two patients were included. The nonsteroid cohort (N = 29) received an average of 467 ± 94.1 morphine milligram equivalents (MME), and the steroid cohort (N = 43) received an average of 285 ± 128 MME (P < 0.001). The nonsteroid cohort consumed 1.62 times more opioids than the steroid cohort (P < 0.002). There were no significant differences in complication or refill rates between treatment groups. There were no significant differences in pain scores on the day of surgery or postoperative days 1, 5, or 10 (P = 0.34, P = 0.66, P = 0.62, and P = 0.22, respectively). Patients undergoing T&A (p = 0.019) or who had current psychiatric medication use (P < 0.006) consumed significantly more opioids. Patients who received a total opioid prescription of >300 MME (40 5-mL doses of 5 mg/5 mL liquid oxycodone) consumed 2.27 times more postoperative opioids than patients with opioid prescriptions ≤300 MME (P < 0.001). CONCLUSION: Patients who did not receive steroids consumed 1.62 times more postoperative opioids compared to those who completed a steroid taper. Corticosteroid use was not associated with changes in pain scores, refill rates, or complication rates and may be considered in a multimodal approach to pain management in adults undergoing benign oropharyngeal surgery, although further study is warranted.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Butkus JM, Sagalow ES, Alfonsi S, et al. Prednisone Decreases Opioid Use in Adults Undergoing Benign Oropharyngeal Surgery. Otolaryngol Head Neck Surg. 2023. PMID: 37702155. doi:10.1002/ohn.515

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。